NYSE · EVH
Healthcare · Medical - Healthcare Information Services
$4.87
Up+$0.39 (+8.71%)
Updated Oct 21, 2026, 10:36 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · EVH
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
EVH closed at $4.87 after 21 trading sessions, up 28.16% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $4.52 | $4.895 | $4.51 | $4.87 | 1.18M |
| Oct 19, 2026 | $4.52 | $4.625 | $4.385 | $4.48 | 1.64M |
| Oct 16, 2026 | $4.89 | $4.95 | $4.55 | $4.57 | 2.08M |
| Oct 15, 2026 | $4.75 | $5.115 | $4.75 | $4.87 | 3.84M |
| Oct 14, 2026 | $4.52 | $4.76 | $4.4862 | $4.73 | 2.27M |
| Oct 13, 2026 | $4.30 | $4.71 | $4.165 | $4.60 | 2.56M |
| Oct 12, 2026 | $4.04 | $4.25 | $4.04 | $4.25 | 1.18M |
| Oct 9, 2026 | $4.00 | $4.18 | $3.98 | $4.04 | 1.07M |
| Oct 8, 2026 | $4.10 | $4.125 | $3.84 | $3.96 | 2.88M |
| Oct 7, 2026 | $3.79 | $4.175 | $3.775 | $4.14 | 2.8M |
| Oct 6, 2026 | $3.66 | $3.87 | $3.63 | $3.84 | 1.59M |
| Oct 5, 2026 | $3.45 | $3.645 | $3.441 | $3.61 | 1.34M |
| Oct 2, 2026 | $3.42 | $3.575 | $3.32 | $3.46 | 1.77M |
| Oct 1, 2026 | $3.48 | $3.51 | $3.34 | $3.39 | 1.97M |
| Sep 30, 2026 | $3.53 | $3.575 | $3.41 | $3.49 | 1.7M |
| Sep 29, 2026 | $3.68 | $3.68 | $3.45 | $3.52 | 3.26M |
| Sep 28, 2026 | $3.57 | $3.715 | $3.4901 | $3.65 | 3.4M |
| Sep 25, 2026 | $3.52 | $3.655 | $3.435 | $3.61 | 2.99M |
| Sep 24, 2026 | $3.62 | $3.66 | $3.51 | $3.52 | 1.89M |
| Sep 23, 2026 | $3.73 | $3.78 | $3.60 | $3.62 | 1.01M |
| Sep 22, 2026 | $3.72 | $3.81 | $3.65 | $3.80 | 1.53M |
The latest Smart Investors Daily articles mentioning EVH.
Company
Market Activity
Research & News
EVH research
Company profile and research snapshot.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 18, 2026 | JP Morgan | Overweight | — |
| Aug 17, 2026 | TD Cowen | Buy | — |
| Aug 12, 2026 | Truist Securities | Hold | — |
| Aug 11, 2026 | Citigroup | Buy | — |
| Aug 10, 2026 | Canaccord Genuity | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 9, 2026
Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter 2026 financial results on Thursday, November 5, 2026, before market open, with a conference call to follow at 8:30 a.m. ET.
Yahoo · Sep 21, 2026
The past six months have been a windfall for Evolent Health’s shareholders. The company’s stock price has jumped 48.6%, hitting $3.70 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Yahoo · Sep 21, 2026
Expanded Partnership Strengthens Language Access and Provides Greater Visibility Across Evolent’s Payer Network Key Takeaways Enterprise-wide telephonic interpretation expands language access for members with limited English proficiency.Centralized reporting improves oversight of language services and supports compliance efforts.AI-enabled technology and professional interpreters deliver fast, reliable service. NEW YORK, Sept. 21, 2026 (GLOBE NEWSWIRE) -- TransPerfect, the world’s leading provid
Yahoo · Sep 16, 2026
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:EVH) and its peers.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EVH.
